Cardlytics, Inc. (NASDAQ:CDLX – Get Rating) Director Scott D. Grimes sold 4,098 shares of the stock in a transaction dated Tuesday, April 19th. The stock was sold at an average price of $50.09, for a total transaction of $205,268.82. Following the sale, the director now directly owns 243,606 shares in the company, valued at $12,202,224.54. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.
Cardlytics stock traded down $5.52 during midday trading on Thursday, reaching $40.95. The company had a trading volume of 685,626 shares, compared to its average volume of 382,388. The company has a market capitalization of $1.38 billion, a P/E ratio of -10.29 and a beta of 2.32. Cardlytics, Inc. has a 12-month low of $39.07 and a 12-month high of $145.00. The firm’s fifty day simple moving average is $54.91 and its 200-day simple moving average is $66.44. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.10 and a quick ratio of 1.10.
Cardlytics (NASDAQ:CDLX – Get Rating) last issued its quarterly earnings results on Tuesday, March 1st. The company reported ($0.15) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.76) by $0.61. The firm had revenue of $90.05 million for the quarter, compared to analyst estimates of $76.59 million. Cardlytics had a negative net margin of 48.13% and a negative return on equity of 12.16%. Cardlytics’s quarterly revenue was up 34.2% compared to the same quarter last year. During the same period last year, the company posted ($0.32) EPS. On average, analysts expect that Cardlytics, Inc. will post -3.64 EPS for the current fiscal year.
Hedge funds have recently added to or reduced their stakes in the business. Dark Forest Capital Management LP acquired a new stake in Cardlytics in the 3rd quarter valued at about $39,000. Rockefeller Capital Management L.P. raised its holdings in Cardlytics by 1.5% in the 3rd quarter. Rockefeller Capital Management L.P. now owns 194,229 shares of the company’s stock valued at $16,303,000 after acquiring an additional 2,938 shares during the last quarter. Russell Investments Group Ltd. raised its holdings in Cardlytics by 98.3% in the 4th quarter. Russell Investments Group Ltd. now owns 70,803 shares of the company’s stock valued at $4,677,000 after acquiring an additional 35,099 shares during the last quarter. Baillie Gifford & Co. raised its holdings in Cardlytics by 23.1% in the 4th quarter. Baillie Gifford & Co. now owns 917,876 shares of the company’s stock valued at $60,662,000 after acquiring an additional 172,072 shares during the last quarter. Finally, Jump Financial LLC raised its holdings in Cardlytics by 151.8% in the 3rd quarter. Jump Financial LLC now owns 26,436 shares of the company’s stock valued at $2,219,000 after acquiring an additional 15,936 shares during the last quarter. Institutional investors own 96.44% of the company’s stock.
About Cardlytics (Get Rating)
Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.
- Get a free copy of the StockNews.com research report on Cardlytics (CDLX)
- NextEra Energy Offers a Long-Term Gain if You Can Tolerate Short-Term Pain
- Steel Dynamics Scales New Heights On Record Results
- The Institutions Are Driving Knight-Swift Transportation
- Tesla (NASDAQ: TSLA) Stock Hits Four Figures Once Again
- 3 Legendary Low-Beta Stocks Set to Outperform
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.